Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

LLineage Cell Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
L

Lineage Cell Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $1.07M. Net result $1.54M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $1.07M. Running result $1.07M. Collaboration Revenues: $943K. Royalties License And Other Revenues: $126K.
  • Cost of royalties: $0. Running result $1.07M.
  • Research and development: −$4.77M. Running result −$3.71M.
  • General and administrative: −$5.22M. Running result −$8.92M.
  • Loss on impairment of intangible asset (Note 6 and Note 13): $0. Running result −$8.92M.
  • Operating income: −$8.92M. Running result −$8.92M.
  • Other income: $10.47M. Running result $1.54M.
  • Pre-tax income: $1.54M. Running result $1.54M.
  • Income tax benefit: $0. Running result $1.54M.
  • Net income: $1.54M. Running result $1.54M.